Interactive Learning Method in Nursing Education

August 28, 2023 updated by: Yadigar Ordu, Çankırı Karatekin University

The Effect of Interactive Learning Method on Nursing Students' Learning of Movement Needs: A Randomized Controlled Study

The research will be conducted to determine the effect of the interactive learning method on the learning of the movement requirement of nursing students. 192 first-year students enrolled in a nursing faculty in Turkey will form the universe. Students who meet the criteria for inclusion in the research will be randomly assigned to the experimental and control groups according to their academic achievement scores. It is envisaged that the research will be completed with approximately 160 students (80=experiment, 80=control). The data of the research will be collected with the "Descriptive Characteristics Form", "Movement Requirement Knowledge Test", "Case Analysis" and "Student Opinion Evaluation Form for Interactive Learning". Expert opinions are taken on the data collection forms. Necessary revisions will be made accordingly. A case for educational purposes This case example was prepared. This case study will be taught to the control group in the classroom with the traditional method. The same case study will be taught to the experimental group in the classroom with the interactive learning method. The Easytestmaker application will be used in the interactive learning method. The data collection forms will be applied to the groups in the form of pre-application and post-application. At the end of the research data will be analyzed.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The introductory characteristics form consists of four closed-ended questions (age, gender, GPA, graduated high school) prepared to determine the demographic characteristics of the students. The movement requirement knowledge test consists of 15 questions, each of which has five options, prepared by the researchers in line with the literature in order to determine the students' knowledge levels about their movement needs. The questions were prepared in accordance with Bloom's taxonomy. In this context, considering that the students are in the first grade, three questions are for knowledge, three for comprehension, three for analysis, three for synthesis, and three for evaluation. After the test is prepared, it will be examined by a total of three experts, including a faculty member who is an expert in the field of Measurement and Evaluation and two faculty members who are experts in the field of Nursing Principles (1: Appropriate, 2: Appropriate but insufficient, 3: Not suitable). The concordance between expert opinions will be analyzed by Kendall's W test. Correct answers in the test will be evaluated as "10" points and wrong answers as "0" points. In this context, a minimum of "0" points and the highest "150" points can be obtained from the test. An increase in the score obtained from the test will show that the students' level of knowledge about movement needs is high. In the case analysis, correct answers given by the students will be evaluated as "10" points, and incorrect answers as "0" points. In this context, points will be made according to each correct and incorrect answer given by the students to the open-ended questions. An increase in the score will show that the students' case analysis skills for movement needs are high. The student opinion evaluation form on interactive learning was prepared by the researchers by scanning the literature in order to evaluate the opinions of the students in the experimental group about the interactive learning method. In this context, the form consists of 10 questions including five-point Likert-type scoring. After the theoretical training, the principal researcher will give the students an introductory feature form and will be asked to fill it in the classroom.Movement requirement knowledge test and evaluation case pre-test and post-test applications will be made. At the end of the study, students in the experimental group will be asked to fill in an evaluation form for the interactive learning method in order to get their opinions on the interactive learning method.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
105

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Konya
      • Merkez, Konya, Turkey
        • Necmettin Erbakan University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Taking the Nursing Fundamentals course for the first time
  • Volunteering to participate in research

Exclusion Criteria:

  • Graduating from a health-related high school or university
  • Difficulty speaking and understanding Turkish
  • Not participating in theoretical training
  • Not participating in group work
  • Not participating in interactive learning
  • Not filling out data collection forms wanting to leave research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
No Intervention: Control
It is the group in which the traditional learning method will be used.
Experimental: Experimental
It is the group in which the interactive learning method will be used.
Other: Training method intervention
Traditional learning method will be used in the control group. In the experimental group, interactive learning method will be used.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
The knowledge level of the students regarding the movement needs will be evaluated.
Time Frame: up to 1 month
Evaluation will be in the form of a movement requirement knowledge test, an evaluation case, and a pre-test and post-test. Detailed information about data collection forms is given. After the post-test, the opinions of the students in the experimental group on interactive learning will be taken with the evaluation form.
up to 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Çankırı Karatekin University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 15, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 22, 2023

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 29, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 30, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 10, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 22, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 30, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 28, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • ErbakanU.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings